LONDON, April 01, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will host an R&D investor event on Wednesday, April 23, 2025 at 8:30am EDT / 13:30pm BST. The live event will be held in New York City. To inquire about in-person attendance please email: susan@sanoonan.com. Amanda Cray +1 617-967-0207 a.cray@autolus.com About Au ...